Aarti Drugs Ltd (BOM:524348)
₹ 490.15 -5.35 (-1.08%) Market Cap: 44.74 Bil Enterprise Value: 50.34 Bil PE Ratio: 29.56 PB Ratio: 3.50 GF Score: 92/100

Q4 2020 Aarti Drugs Ltd Earnings Call Transcript

May 18, 2020 / NTS GMT
Operator

(technical difficulty) at Aarti Drugs conference call hosted by Centrum Broking Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Cyndrella Carvalho from Centrum Broking. Thank you, and over to you, ma'am.

Cyndrella Carvalho
Centrum Broking Pvt. Ltd. - Analyst

Good afternoon, everyone. On behalf of Centrum Broking, I welcome you all on today's Aarti Drugs earnings con-call for the fourth quarter. I take a moment to thank the management for giving us this opportunity and their time. From the management today, we have with us Mr. Harshit Savla, Joint Managing Director, Mr. Harit Shah, Whole-Time Director, Mr. Adhish Patil, our CFO, Mr. Vishwa Savla, Director, Pinnacle Life Sciences. Over to Adhish, CFO, please.

Adhish Patil
Aarti Drugs Ltd. - CFO

Hi. Thank you for your introduction [here]. We welcome you all for the conference call of Arti Drugs Ltd. I think the main purpose of the call, as we all know, is to (inaudible) about the quarterly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot